{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T04:58:38Z","timestamp":1793336318911,"version":"4.5.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T00:00:00Z","timestamp":1662336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T00:00:00Z","timestamp":1662336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-022-03655-6","type":"journal-article","created":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T10:15:01Z","timestamp":1662372901000},"page":"136-150","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Primary sclerosing cholangitis: review for radiologists"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8956-4483","authenticated-orcid":false,"given":"Matthew A.","family":"Morgan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3448-4528","authenticated-orcid":false,"given":"Rachita","family":"Khot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9392-7910","authenticated-orcid":false,"given":"Karthik M.","family":"Sundaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8131-3003","authenticated-orcid":false,"given":"Daniel R.","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6390-9877","authenticated-orcid":false,"given":"Rashmi T.","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3302-8590","authenticated-orcid":false,"given":"Pardeep K.","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5027-3347","authenticated-orcid":false,"given":"Dhakshina M.","family":"Ganeshan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7514-1030","authenticated-orcid":false,"given":"Sudhakar K.","family":"Venkatesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,5]]},"reference":[{"issue":"5","key":"3655_CR1","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nrgastro.2016.154","volume":"14","author":"X Jiang","year":"2017","unstructured":"Jiang X, Karlsen TH. Genetics of primary sclerosing cholangitis and pathophysiological implications.\u00a0Nat Rev Gastroenterol Hepatol.\u00a02017;14(5):279-95.","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"3655_CR2","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1136\/gutjnl-2015-311004","volume":"65","author":"J Sabino","year":"2016","unstructured":"Sabino J, Vieira-Silva S, Machiels K, et al. Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD. Gut 2016; 65: 1681\u201389.","journal-title":"Gut"},{"issue":"10139","key":"3655_CR3","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1016\/S0140-6736(18)30300-3","volume":"391","author":"JK Dyson","year":"2018","unstructured":"Dyson JK, Beuers U, Jones DEJ, Lohse AW, Hudson M. Primary sclerosing cholangitis. Lancet. 2018;391(10139):2547-59.","journal-title":"Lancet."},{"key":"3655_CR4","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1002\/hep.23810","volume":"52","author":"U Beuers","year":"2010","unstructured":"Beuers U, Hohenester S, de Buy Wenniger LJ, Kremer AE, Jansen PL, Elferink RP. The biliary HCO(3)(-) umbrella: a unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies. Hepatology 2010; 52: 1489\u201396.","journal-title":"Hepatology"},{"key":"3655_CR5","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jhep.2009.01.023","volume":"51","author":"G Rudolph","year":"2009","unstructured":"Rudolph G, Gotthardt D, Kloters-Plachky P, Kulaksiz H, Rost D, Stiehl A. Influence of dominant bile duct stenoses and biliary infections on outcome in primary sclerosing cholangitis. J Hepatol 2009; 51: 149\u201355.","journal-title":"J Hepatol"},{"key":"3655_CR6","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1002\/hep.26565","volume":"58","author":"KB Boonstra","year":"2013","unstructured":"Boonstra KB,\u00a0Weersma RK,\u00a0van Erpecum KJ,\u00a0Rauws EA,\u00a0Spanier BW,\u00a0Poen AC, et al.;\u00a0EpiPSCPBC Study Group.\u00a0Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis.\u00a0Hepatology\u00a02013;58:2045\u20132055.","journal-title":"Hepatology"},{"issue":"10","key":"3655_CR7","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1111\/liv.15007","volume":"41","author":"TI Mehta","year":"2021","unstructured":"Mehta TI, Weissman S, Fung BM, Sotiriadis J, Lindor KD, Tabibian JH. Global incidence, prevalence and features of primary sclerosing cholangitis: A systematic review and meta-analysis. Liver Int. 2021;41(10):2418-26.","journal-title":"Liver Int."},{"key":"3655_CR8","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/ng.3745","volume":"49","author":"SG Ji","year":"2017","unstructured":"Ji SG,\u00a0Juran BD,\u00a0Mucha S,\u00a0Folseras T,\u00a0Jostins L,\u00a0Melum E, et al.\u00a0Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease.\u00a0Nat Genet\u00a02017;49:269\u2013273.","journal-title":"Nat Genet"},{"issue":"5","key":"3655_CR9","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/cld.633","volume":"9","author":"RW Chapman","year":"2017","unstructured":"Chapman RW. Update on primary sclerosing cholangitis.\u00a0Clin Liver Dis (Hoboken).\u00a02017;9(5):107-10.","journal-title":"Clin Liver Dis (Hoboken)."},{"key":"3655_CR10","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0168-8278(01)00288-4","volume":"36","author":"A Bergquist","year":"2002","unstructured":"Bergquist A,\u00a0Ekbom A,\u00a0Olsson R,\u00a0Kornfeldt D,\u00a0Loof L,\u00a0Danielsson A, et al.\u00a0Hepatic and extrahepatic malignancies in primary sclerosing cholangitis.\u00a0J Hepatol\u00a02002;\u00a036:\u00a0321-327.","journal-title":"J Hepatol"},{"issue":"30","key":"3655_CR11","doi-asserted-by":"publisher","first-page":"4148","DOI":"10.3748\/wjg.v25.i30.4148","volume":"25","author":"WT Clarke","year":"2019","unstructured":"Clarke WT, Feuerstein JD. Colorectal cancer surveillance in inflammatory bowel disease: Practice guidelines and recent developments.\u00a0World J Gastroenterol.\u00a02019;25(30):4148-57.","journal-title":"World J Gastroenterol."},{"key":"3655_CR12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jaut.2013.07.004","volume":"46","author":"GF Mells","year":"2013","unstructured":"Mells, G. F., Kaser, A. & Karlsen, T. H. Novel insights into autoimmune liver diseases provided by genome-wide association studies. J. Autoimmun. 46, 41\u201354 (2013).","journal-title":"J. Autoimmun."},{"issue":"3","key":"3655_CR13","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/cld.902","volume":"15","author":"E Gochanour","year":"2020","unstructured":"Gochanour E, Jayasekera C, Kowdley K. Primary Sclerosing Cholangitis: Epidemiology, Genetics, Diagnosis, and Current Management.\u00a0Clin Liver Dis (Hoboken).\u00a02020;15(3):125-8.","journal-title":"Clin Liver Dis (Hoboken)."},{"key":"3655_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2021.08.039","author":"PJ Trivedi","year":"2022","unstructured":"Trivedi PJ, Bowlus CL, Yimam KK, Razavi H, Estes C. Epidemiology, Natural History, and Outcomes of Primary Sclerosing Cholangitis: A Systematic Review of Population-based Studies. Clin Gastroenterol Hepatol. https:\/\/doi.org\/10.1016\/j.cgh.2021.08.039","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3655_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-022-03551-z","author":"DR Ludwig","year":"2022","unstructured":"Ludwig DR, Anderson MA, Itani M, Sharbidre KG, Lalwani N, Paspulati RM. Secondary sclerosing cholangitis: mimics of primary sclerosing cholangitis.\u00a0Abdom Radiol (NY).\u00a0https:\/\/doi.org\/10.1007\/s00261-022-03551-z","journal-title":"Abdom Radiol (NY)"},{"key":"3655_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-022-03440-5","author":"KM Sundaram","year":"2022","unstructured":"Sundaram KM, Morgan MA, Itani M, Thompson W. Imaging of benign biliary pathologies. Abdom Radiol (NY). https:\/\/doi.org\/10.1007\/s00261-022-03440-5","journal-title":"Abdom Radiol (NY)"},{"key":"3655_CR17","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1002\/hep.21405","volume":"44","author":"R Abdalian","year":"2006","unstructured":"Abdalian R, Heathcote EJ. Sclerosing cholangitis: a focus on secondary causes. HEPATOLOGY 2006;44:1063-1074.","journal-title":"HEPATOLOGY"},{"issue":"4","key":"3655_CR18","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1053\/j.gastro.2008.01.042","volume":"134","author":"E Bj\u00f6rnsson","year":"2008","unstructured":"Bj\u00f6rnsson E, Olsson R, Bergquist A, et al. The natural history of small-duct primary sclerosing cholangitis.\u00a0Gastroenterology.\u00a02008;134(4):975-80.","journal-title":"Gastroenterology."},{"issue":"12","key":"3655_CR19","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1016\/j.cgh.2019.07.011","volume":"17","author":"CL Bowlus","year":"2019","unstructured":"Bowlus CL, Lim JK, Lindor KD. AGA Clinical Practice Update on Surveillance for Hepatobiliary Cancers in Patients With Primary Sclerosing Cholangitis: Expert Review.\u00a0Clin Gastroenterol Hepatol.\u00a02019;17(12):2416-22.","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"8","key":"3655_CR20","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1007\/s00261-020-02572-w","volume":"45","author":"K Kozaka","year":"2020","unstructured":"Kozaka K, Sheedy SP, Eaton JE, Venkatesh SK, Heiken JP. Magnetic resonance imaging features of small-duct primary sclerosing cholangitis. Abdom Radiol (NY). 2020;45(8):2388-99.","journal-title":"Abdom Radiol (NY)."},{"key":"3655_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2020.109101","volume":"129","author":"KI Ringe","year":"2020","unstructured":"Ringe KI, Bergquist A, Lenzen H, et al. Clinical features and MRI progression of small duct primary sclerosing cholangitis (PSC).\u00a0Eur J Radiol.\u00a02020;129:109101.","journal-title":"Eur J Radiol."},{"issue":"10","key":"3655_CR22","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1111\/liv.12492","volume":"34","author":"S Naess","year":"2014","unstructured":"Naess S, Bj\u00f6rnsson E, Anmarkrud JA, et al. Small duct primary sclerosing cholangitis without inflammatory bowel disease is genetically different from large duct disease.\u00a0Liver Int.\u00a02014;34(10):1488-95.","journal-title":"Liver Int."},{"issue":"6","key":"3655_CR23","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S0168-8278(96)80266-2","volume":"24","author":"F Gohlke","year":"1996","unstructured":"Gohlke F, Lohse AW, Dienes HP, et al. Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis.\u00a0J Hepatol.\u00a01996;24(6):699-705.","journal-title":"J Hepatol."},{"issue":"Suppl(1)","key":"3655_CR24","doi-asserted-by":"publisher","first-page":"S93","DOI":"10.1016\/j.jhep.2004.11.009","volume":"42","author":"U Beuers","year":"2005","unstructured":"Beuers U. Hepatic overlap syndromes.\u00a0J Hepatol.\u00a02005;42 Suppl(1):S93-9.","journal-title":"J Hepatol."},{"issue":"5","key":"3655_CR25","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.clinre.2011.10.007","volume":"36","author":"PJ Trivedi","year":"2012","unstructured":"Trivedi PJ, Chapman RW. PSC, AIH and overlap syndrome in inflammatory bowel disease.\u00a0Clin Res Hepatol Gastroenterol.\u00a02012;36(5):420-36.","journal-title":"Clin Res Hepatol Gastroenterol."},{"issue":"2","key":"3655_CR26","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1365-2036.2008.03722.x","volume":"28","author":"T Al-Chalabi","year":"2008","unstructured":"Al-Chalabi T, Portmann BC, Bernal W, McFarlane IG, Heneghan MA. Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival.\u00a0Aliment Pharmacol Ther.\u00a02008;28(2):209-20.","journal-title":"Aliment Pharmacol Ther."},{"issue":"2","key":"3655_CR27","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/jmri.22048","volume":"31","author":"WB Hyslop","year":"2010","unstructured":"Hyslop WB, Kierans AS, Leonardou P, et al. Overlap syndrome of autoimmune chronic liver diseases: MRI findings.\u00a0J Magn Reson Imaging.\u00a02010;31(2):383-9.","journal-title":"J Magn Reson Imaging."},{"key":"3655_CR28","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1572-0241.2006.00872.x","volume":"102","author":"JJ Tischendorf","year":"2007","unstructured":"Tischendorf JJ, Hecker H, Kr\u00fcger M, Manns MP, Meier PN. Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: a single center study. Am J Gastroenterol. 2007; 102:107\u2013114.","journal-title":"Am J Gastroenterol."},{"key":"3655_CR29","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1148\/radiographics.20.4.g00jl04959","volume":"20","author":"KM Vitellas","year":"2000","unstructured":"Vitellas KM, Keogan MT, Freed KS, Enns RA, Spritzer CE, Baillie JM, et al. Radiologic manifestations of sclerosing cholangitis with emphasis on MR cholangiopancreatography. Radiographics. 2000; 20:959\u2013975. quiz 1108-1109, 1112","journal-title":"Radiographics."},{"issue":"7","key":"3655_CR30","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1148\/rg.2019180213","volume":"39","author":"Pegah Khoshpouri","year":"2019","unstructured":"Khoshpouri, Pegah, et al. \"Imaging features of primary sclerosing cholangitis: from diagnosis to liver transplant follow-up.\"\u00a0Radiographics\u00a039.7 (2019): 1938-1964.","journal-title":"Radiographics"},{"issue":"2","key":"3655_CR31","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1007\/s00330-021-08147-7","volume":"32","author":"SK Venkatesh","year":"2022","unstructured":"Venkatesh SK, Welle CL, Miller FH, Jhaveri K, Ringe KI, Eaton JE, Bungay H, Arriv\u00e9 L, Ba-Ssalamah A, Grigoriadis A, Schramm C, Fulcher AS; IPSCSG. Reporting standards for primary sclerosing cholangitis using MRI and MR cholangiopancreatography: guidelines from MR Working Group of the International Primary Sclerosing Cholangitis Study Group. Eur Radiol. 2022 Feb;32(2):923-937. PMID: 34363134.","journal-title":"Eur Radiol."},{"issue":"2","key":"3655_CR32","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/BF00201514","volume":"20","author":"CBLM Majoie","year":"1995","unstructured":"Majoie, C. B. L. M., et al. \"Primary sclerosing cholangitis: sonographic findings.\" Abdominal imaging 20.2 (1995): 109-112.","journal-title":"Abdominal imaging"},{"key":"3655_CR33","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1097\/00004728-198310000-00007","volume":"7","author":"AE Ament","year":"1983","unstructured":"Ament AE, Haaga JR, Wiedenmann SD, Barkmeier JD, Morrison SC. Primary sclerosing cholangitis: CT findings. J Comput Assist Tomogr. 1983; 7:795\u2013800.","journal-title":"J Comput Assist Tomogr."},{"issue":"12","key":"3655_CR34","doi-asserted-by":"publisher","first-page":"3260","DOI":"10.1007\/s00261-018-1590-4.PMID:29626258;PMCID:PMC6731546","volume":"43","author":"CA Bookwalter","year":"2018","unstructured":"Bookwalter CA, Venkatesh SK, Eaton JE, Smyrk TD, Ehman RL. MR elastography in primary sclerosing cholangitis: correlating liver stiffness with bile duct strictures and parenchymal changes. Abdom Radiol (NY). 2018 Dec;43(12):3260-3270. doi: https:\/\/doi.org\/10.1007\/s00261-018-1590-4. PMID: 29626258; PMCID: PMC6731546.","journal-title":"Abdom Radiol (NY)."},{"issue":"1","key":"3655_CR35","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s00261-016-0847-z","volume":"42","author":"JM Ni Mhuircheartaigh","year":"2017","unstructured":"Ni Mhuircheartaigh JM, Lee KS, Curry MP, Pedrosa I, Mortele KJ. Early Peribiliary Hyperenhancement on MRI in Patients with Primary Sclerosing Cholangitis: Significance and Association with the Mayo Risk Score. Abdom Radiol (NY) 2017;42(1):152\u2013158.","journal-title":"Abdom Radiol (NY)"},{"issue":"4","key":"3655_CR36","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1136\/gut.39.4.594.PMID:8944571;PMCID:PMC1383275","volume":"39","author":"PC van de Meeberg","year":"1996","unstructured":"van de Meeberg PC, Portincasa P, Wolfhagen FH, van Erpecum KJ, VanBerge-Henegouwen GP. Increased gall bladder volume in primary sclerosing cholangitis. Gut. 1996 Oct;39(4):594-9. doi: https:\/\/doi.org\/10.1136\/gut.39.4.594. PMID: 8944571; PMCID: PMC1383275.","journal-title":"Gut."},{"key":"3655_CR37","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/cld.334","volume":"3","author":"RW Chapman","year":"2014","unstructured":"Chapman RW.\u00a0Malignancy in PSC: bile duct, liver and colon.\u00a0Clin Liver Dis\u00a02014;3:83\u201385.","journal-title":"Clin Liver Dis"},{"key":"3655_CR38","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/apt.13004","volume":"41","author":"KD Williamson","year":"2014","unstructured":"Williamson KD,\u00a0Chapman RW.\u00a0Further evidence for the role of serum alkaline phosphatase as a useful surrogate marker in primary sclerosing cholangitis?\u00a0Aliment Pharmacol Ther\u00a02014;41:149\u2013151.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"3655_CR39","volume":"11","author":"N Patel","year":"2019","unstructured":"Patel N, Benipal B. Incidence of Cholangiocarcinoma in the USA from 2001 to 2015: A US Cancer Statistics Analysis of 50 States. Cureus. 2019 Jan 25;11(1):e3962.","journal-title":"Cureus."},{"key":"3655_CR40","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/j.1572-0241.2004.04067.x","volume":"99","author":"K Burak","year":"2004","unstructured":"Burak K,\u00a0Angulo P,\u00a0Pasha TM,\u00a0Egan K,\u00a0Petz J,\u00a0Lindor KD.\u00a0Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis.\u00a0Am J Gastroenterol\u00a02004;\u00a099:\u00a0523-526.","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"3655_CR41","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1002\/hep.26565","volume":"58","author":"K Boonstra","year":"2013","unstructured":"Boonstra K, Weersma RK, van Erpecum KJ, et al. EpiPSCPBC Study Group. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis.\u00a0Hepatology.\u00a02013;58(6):2045\u20132055.","journal-title":"Hepatology."},{"issue":"10","key":"3655_CR42","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.3109\/00365529709011222","volume":"32","author":"D Kornfeld","year":"1997","unstructured":"Kornfeld D, Ekbom A, Ihre T. Survival and Risk of Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis: A Population-Based Study. Scandinavian Journal of Gastroenterology. 1997 Jan 1;32(10):1042\u20135.","journal-title":"Scandinavian Journal of Gastroenterology."},{"issue":"S1","key":"3655_CR43","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/liv.14095","volume":"39","author":"SA Khan","year":"2019","unstructured":"Khan SA, Tavolari S, Brandi G. Cholangiocarcinoma: Epidemiology and risk factors. Liver International. 2019;39(S1):19\u201331.","journal-title":"Liver International."},{"issue":"6","key":"3655_CR44","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1002\/hep.29730","volume":"67","author":"AH Ali","year":"2018","unstructured":"Ali AH, Tabibian JH, Nasser-Ghodsi N, Lennon RJ, DeLeon T, Borad MJ, et al. Surveillance for hepatobiliary cancers in patients with primary sclerosing cholangitis. Hepatology. 2018;67(6):2338\u201351.","journal-title":"Hepatology."},{"key":"3655_CR45","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/hep.23294","volume":"51","author":"R Chapman","year":"2010","unstructured":"Chapman R,\u00a0Fevery J,\u00a0Kalloo A,\u00a0Nagorney DM,\u00a0Boberg KM,\u00a0Shneider B,\u00a0Gores GJ.\u00a0Diagnosis and management of primary sclerosing cholangitis.\u00a0Hepatology\u00a02010;\u00a051:\u00a0660-678.","journal-title":"Hepatology"},{"issue":"3","key":"3655_CR46","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","volume":"75","author":"A Berzigotti","year":"2021","unstructured":"Berzigotti A, Tsochatzis E, Boursier J, et al. EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update.\u00a0J Hepatol.\u00a02021;75(3):659-89.","journal-title":"J Hepatol."},{"key":"3655_CR47","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1002\/hep.29293","volume":"66","author":"C Schramm","year":"2017","unstructured":"Schramm C,\u00a0Eaton J,\u00a0Ringe KI, et al;\u00a0MRI Working Group of the IPSCSG.\u00a0Recommendations on the use of magnetic resonance imaging in PSC-A position statement from the International PSC Study Group.\u00a0Hepatology\u00a02017;66:1675-1688.","journal-title":"Hepatology"},{"issue":"4","key":"3655_CR48","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1002\/hep.22441","volume":"48","author":"P Charatcharoenwitthaya","year":"2008","unstructured":"Charatcharoenwitthaya P, Enders FB, Halling KC, Lindor KD. Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis. Hepatology. 2008;48(4):1106\u201317.","journal-title":"Hepatology."},{"issue":"5","key":"3655_CR49","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.2214\/ajr.145.5.1061","volume":"145","author":"G May","year":"1985","unstructured":"May G, Bender C, LaRusso N, Wiesner R. Nonoperative dilatation of dominant strictures in primary sclerosing cholangitis. American Journal of Roentgenology. 1985 Nov 1;145(5):1061\u20134.","journal-title":"American Journal of Roentgenology."},{"issue":"2","key":"3655_CR50","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0168-8278(01)00251-3","volume":"36","author":"A Stiehl","year":"2002","unstructured":"Stiehl A, Rudolph G, Kl\u00f6ters-Plachky P, Sauer P, Walker S. Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment. Journal of Hepatology. 2002 Feb;36(2):151\u20136.","journal-title":"Journal of Hepatology."},{"issue":"2","key":"3655_CR51","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s11901-017-0341-2","volume":"16","author":"RW Chapman","year":"2017","unstructured":"Chapman RW, Williamson KD. Are Dominant Strictures in Primary Sclerosing Cholangitis a Risk Factor for Cholangiocarcinoma? Curr Hepatology Rep. 2017 Jun 1;16(2):124\u20139.","journal-title":"Curr Hepatology Rep."},{"issue":"5","key":"3655_CR52","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1002\/hep.31575","volume":"73","author":"JE Eaton","year":"2021","unstructured":"Eaton JE, Welle CL, Bakhshi Z, Sheedy SP, Idilman IS, Gores GJ, Rosen CB, Heimbach JK, Taner T, Harnois DM, Lindor KD, LaRusso NF, Gossard AA, Lazaridis KN, Venkatesh SK. Early Cholangiocarcinoma Detection With Magnetic Resonance Imaging Versus Ultrasound in Primary Sclerosing Cholangitis. Hepatology. 2021 May;73(5):1868-1881. doi: https:\/\/doi.org\/10.1002\/hep.31575.","journal-title":"Hepatology."},{"issue":"9904","key":"3655_CR53","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/S0140-6736(13)60096-3","volume":"382","author":"GM Hirschfield","year":"2013","unstructured":"Hirschfield GM, Karlsen TH, Lindor KD, Adams DH. Primary sclerosing cholangitis. Lancet. 2013;382(9904):1587-99.","journal-title":"Lancet."},{"issue":"4","key":"3655_CR54","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.jhep.2007.11.019","volume":"48","author":"K Said","year":"2008","unstructured":"Said K, Glaumann H, Bergquist A. Gallbladder disease in patients with primary sclerosing cholangitis. J Hepatol. 2008;48(4):598-605.","journal-title":"J Hepatol."},{"issue":"6","key":"3655_CR55","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.rcl.2017.06.005","volume":"55","author":"K Sandrasegaran","year":"2017","unstructured":"Sandrasegaran K, Menias CO. Imaging and Screening of Cancer of the Gallbladder and Bile Ducts. Radiol Clin North Am. 2017;55(6):1211-22.","journal-title":"Radiol Clin North Am."},{"issue":"2","key":"3655_CR56","doi-asserted-by":"publisher","first-page":"W150","DOI":"10.2214\/AJR.13.11992","volume":"204","author":"JH Kim","year":"2015","unstructured":"Kim JH, Lee JY, Baek JH, et al. High-resolution sonography for distinguishing neoplastic gallbladder polyps and staging gallbladder cancer. AJR Am J Roentgenol. 2015;204(2):W150-9.","journal-title":"AJR Am J Roentgenol."},{"issue":"12","key":"3655_CR57","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.jacr.2013.05.022","volume":"10","author":"S Sebastian","year":"2013","unstructured":"Sebastian S, Araujo C, Neitlich JD, Berland LL. Managing incidental findings on abdominal and pelvic CT and MRI, Part 4: white paper of the ACR Incidental Findings Committee II on gallbladder and biliary findings. J Am Coll Radiol. 2013;10(12):953-6.","journal-title":"J Am Coll Radiol."},{"issue":"5","key":"3655_CR58","doi-asserted-by":"publisher","first-page":"3358","DOI":"10.1007\/s00330-021-08384-w","volume":"32","author":"KG Foley","year":"2022","unstructured":"Foley KG, Lahaye MJ, Thoeni RF, et al. Management and follow-up of gallbladder polyps: updated joint guidelines between the ESGAR, EAES, EFISDS and ESGE. Eur Radiol. 2022;32(5):3358-68.","journal-title":"EFISDS and ESGE. Eur Radiol."},{"key":"3655_CR59","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.213079","author":"A Kamaya","year":"2022","unstructured":"Kamaya A, Fung C, Szpakowski JL, et al. Management of Incidentally Detected Gallbladder Polyps: Society of Radiologists in Ultrasound Consensus Conference Recommendations. Radiology. https:\/\/doi.org\/10.1148\/radiol.213079","journal-title":"Radiology"},{"issue":"5","key":"3655_CR60","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1002\/hep.24570","volume":"54","author":"N Razumilava","year":"2011","unstructured":"Razumilava N, Gores GJ, Lindor KD. Cancer surveillance in patients with primary sclerosing cholangitis. Hepatology. 2011;54(5):1842-52.","journal-title":"Hepatology."},{"issue":"5","key":"3655_CR61","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1111\/j.1572-0241.2002.05677.x","volume":"97","author":"DC Buckles","year":"2002","unstructured":"Buckles DC, Lindor KD, Larusso NF, Petrovic LM, Gores GJ. In primary sclerosing cholangitis, gallbladder polyps are frequently malignant. Am J Gastroenterol. 2002;97(5):1138-42. doi: https:\/\/doi.org\/10.1111\/j.1572-0241.2002.05677.x.","journal-title":"Am J Gastroenterol."},{"issue":"3","key":"3655_CR62","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1002\/hep.28963","volume":"65","author":"EM de Vries","year":"2017","unstructured":"de Vries EM, de Krijger M, F\u00e4rkkil\u00e4 M, et al. Validation of the prognostic value of histologic scoring systems in primary sclerosing cholangitis: An international cohort study. Hepatology. 2017;65(3):907-19.","journal-title":"Hepatology."},{"issue":"6","key":"3655_CR63","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1111\/jgh.13263.PMID:26691631;PMCID:PMC4885758","volume":"31","author":"JE Eaton","year":"2016","unstructured":"Eaton JE, Dzyubak B, Venkatesh SK, Smyrk TC, Gores GJ, Ehman RL, LaRusso NF, Gossard AA, Lazaridis KN. Performance of magnetic resonance elastography in primary sclerosing cholangitis. J Gastroenterol Hepatol. 2016 Jun;31(6):1184-90. doi: https:\/\/doi.org\/10.1111\/jgh.13263. PMID: 26691631; PMCID: PMC4885758.","journal-title":"J Gastroenterol Hepatol."},{"issue":"7","key":"3655_CR64","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1016\/j.cgh.2019.10.041","volume":"18","author":"JE Eaton","year":"2020","unstructured":"Eaton JE, Sen A, Hoodeshenas S, Schleck CD, Harmsen WS, Gores GJ, LaRusso NF, Gossard AA, Lazaridis KN, Venkatesh SK. Changes in Liver Stiffness, Measured by Magnetic Resonance Elastography, Associated With Hepatic Decompensation in Patients With Primary Sclerosing Cholangitis. Clin Gastroenterol Hepatol. 2020 Jun;18(7):1576-1583.e1. doi: https:\/\/doi.org\/10.1016\/j.cgh.2019.10.041.","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"1","key":"3655_CR65","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/hep.26620","volume":"59","author":"A Ruiz","year":"2014","unstructured":"Ruiz A, Lemoinne S, Carrat F, Corpechot C, Chazouill\u00e8res O, Arriv\u00e9 L. Radiologic course of primary sclerosing cholangitis: assessment by three-dimensional magnetic resonance cholangiography and predictive features of progression. Hepatology. 2014 Jan;59(1):242-50. doi: https:\/\/doi.org\/10.1002\/hep.26620.","journal-title":"Hepatology."},{"issue":"13","key":"3655_CR66","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1016\/j.cgh.2019.03.013","volume":"17","author":"S Lemoinne","year":"2019","unstructured":"Lemoinne S, Cazzagon N, El Mouhadi S, et al. Simple magnetic resonance scores associate with outcomes of patients with primary sclerosing cholangitis. Clin Gastroenterol Hepatol. 2019;17(13):2785-92.e3.","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"6","key":"3655_CR67","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","volume":"67","author":"TH Karlsen","year":"2017","unstructured":"Karlsen TH, Folseraas T, Thorburn D, Vesterhus M. Primary sclerosing cholangitis - a comprehensive review. J Hepatol. 2017;67(6):1298-323.","journal-title":"J Hepatol."},{"key":"3655_CR68","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.ejrad.2018.10.006","volume":"108","author":"P Khoshpouri","year":"2018","unstructured":"Khoshpouri P, Ameli S, Ghasabeh MA, et al. Correlation between quantitative liver and spleen volumes and disease severity in primary sclerosing cholangitis as determined by Mayo risk score. Eur J Radiol 2018;108:254\u2013260.","journal-title":"Eur J Radiol"},{"key":"3655_CR69","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1478-3231.2011.02677.x","volume":"33","author":"D Joshi","year":"2013","unstructured":"Joshi D, Bjarnason I, Belgaumkar A, O\u2019Grady J, Suddle A, Heneghan MA, et al. The impact of inflammatory bowel disease post-liver transplantation for primary sclerosing cholangitis. Liver Int 2013;33:53\u201361.","journal-title":"Liver Int"},{"issue":"9","key":"3655_CR70","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1002\/lt.24496","volume":"22","author":"FD Gordon","year":"2016","unstructured":"Gordon FD, Goldberg DS, Goodrich NP, Lok AS, Verna EC, Selzner N, Stravitz RT, Merion RM. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients. Liver Transpl. 2016 Sep;22(9):1214-22. doi: https:\/\/doi.org\/10.1002\/lt.24496.","journal-title":"Liver Transpl."},{"issue":"8","key":"3655_CR71","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1007\/s11605-009-0898-3","volume":"13","author":"R Kashyap","year":"2009","unstructured":"Kashyap R, Mantry P, Sharma R, Maloo MK, Safadjou S, Qi Y, Jain A, Maliakkal B, Ryan C, Orloff M. Comparative analysis of outcomes in living and deceased donor liver transplants for primary sclerosing cholangitis. J Gastrointest Surg. 2009 Aug;13(8):1480-6. doi: https:\/\/doi.org\/10.1007\/s11605-009-0898-3.","journal-title":"J Gastrointest Surg."},{"key":"3655_CR72","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.jhep.2015.07.005","volume":"63","author":"R Ravikumar","year":"2015","unstructured":"Ravikumar R, Tsochatzis E, Jose S, et al. Risk factors for recurrent primary sclerosing cholangitis after liver transplantation. J Hepatol 2015;63:1139-46.","journal-title":"J Hepatol"},{"key":"3655_CR73","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/lt.24350","volume":"22","author":"T Hildebrand","year":"2016","unstructured":"Hildebrand T, Pannicke N, Dechene A, et al. Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis: a retrospective multicenter analysis. Liver Transpl 2016;22:42-52.","journal-title":"Liver Transpl"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-022-03655-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-022-03655-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-022-03655-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T10:04:13Z","timestamp":1674036253000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-022-03655-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,5]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["3655"],"URL":"https:\/\/doi.org\/10.1007\/s00261-022-03655-6","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,5]]},"assertion":[{"value":"20 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No conflict of interest or competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}